Profile
ISPC DHR-PB TMO DHR IDXX A
Company Name iSpecimen Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $1.83M $916.76B $203.95B $153.12B $51.47B $36.74B
Employees 0.02K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Katharyn Field Rainer M. Blair Marc N. Casper Rainer Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
ISPC DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
ISPC DHR-PB TMO DHR IDXX A
Last Close $0.5803 $1261.26 $567.16 $220.44 $669 $144.52
High 52 $4.61 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $0.58 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -87.41 % 0 % -6.52 % -12.03 % -7.46 % -5.29 %
Price vs. 52 Week Low 0.05 % 0 % 45.35 % 26.23 % 85.3 % 45.55 %
Total Return
ISPC DHR-PB TMO DHR IDXX A
1 Month Return -21.67 % 0 % 5.24 % 5.44 % 5.29 % 1.83 %
3 Month Return -50.4 % 0 % 16.29 % 5.47 % 4.88 % 22.32 %
6 Month Return -48.65 % 0 % 37.64 % 12.41 % 29.13 % 27.03 %
9 Month Return -70.39 % 0 % 8.42 % 7.78 % 48.98 % 6.89 %
YTD Return -78.14 % 0 % 9.02 % -3.97 % 61.81 % 7.58 %
1 Year Return -86.96 % 0 % 11.4 % -4.51 % 60.69 % 14.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ISPC DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.59 % 0.32 % 0.59 % - 0.77 %
Dividend Paid and Capex Coverage Ration (TTM) -202.75 % 3.15 % 3.62 % 3.15 % 9.48 % 2.26 %
Dividend Per Share (TTM) - 1.28 % 1.72 % 1.28 % - 1 %
Payout Ratio (TTM) - 24.29 % 9.47 % 24.29 % - 21.64 %
Growth
ISPC DHR-PB TMO DHR IDXX A
Asset Growth -40.89 % 7.64 % 13.38 % 7.64 % 1.03 %
Gross Profit Growth -21.92 % 5.38 % -5.36 % 5.38 % 8.63 %
Revenue Growth -6.42 % 2.9 % 3.91 % 2.9 % 6.46 %
Revenue 3 Year -52.04 % -5.47 % 3.42 % -5.47 % 25.23 %
Revenue 5 Year -85.77 % 10.08 % 45.65 % 10.08 % 69.09 %
Revenue 10 Year -86.06 % 68 % 178.48 % 68 % 218.38 %
EBIT Growth -16.59 % -7.15 % -6.71 % -7.15 % 3.47 %
Net Income Growth -12.6 % -7.31 % 6.35 % -7.31 % 5.07 %
Net Income 3 Yeari Growth Per Share 19.84 % -48.61 % 1.06 % -48.61 % 23.15 %
Net Income 5 Yeari Growth Per Share 82.59 % -1.03 % 11.3 % -1.03 % 116.76 %
Net Income 10 Yeari Growth Per Share 84.59 % 37.36 % 261.63 % 37.36 % 492.42 %
Operating Income Growth -13.96 % -0.91 % 5.83 % -0.91 % 2.84 %
Operating Cash Flow Growth (CFG) -42.29 % -4.07 % -9.8 % -4.07 % 2.48 %
Operating 3 Year CFG 55.47 % -22.79 % -10.96 % -22.79 % 27.03 %
Operating 5 Year CFG 79.7 % 3.19 % -0.67 % 3.19 % 111.28 %
Operating 10 Year CFG 79.69 % 66.57 % 194.29 % 66.57 % 378.1 %
EPS Growth -1329.27 % -4.88 % 7.18 % -4.88 % 5.9 %
EPS Diluted Growth 28.39 % -4.73 % 7.32 % -4.73 % 6.06 %
Book Value Per Share -78.38 % 9.57 % 9.5 % 9.57 % 8.24 %
Share Holder 3 Year Equity Growth Per Share -93.61 % 7.54 % 26.63 % 7.54 % 138.87 %
Share Holder 5 Year Equity Growth Per Share 100.96 % 31.9 % 63.03 % 31.9 % 838.67 %
Share Holder 10 Year Equity Growth Per Share 101.18 % 118.87 % 165.29 % 118.87 % 1547.69 %
Dividend Per Share Growth - 18.15 % 10.83 % 18.15 % -
Dividend 3 Year Growth Per Share - 10.04 % 45.73 % 10.04 % -
Dividend 5 Year Growth Per Share - 42.54 % 98.76 % 42.54 % -
Dividend 10 Year Growth Per Share - 144.73 % 180.3 % 144.73 % -
Debt Growth 59.07 % 7.42 % 20.17 % 7.42 % -7.53 %
Free Cash Flow Growth 21.39 % -0.68 % -13.4 % -0.68 % 3.26 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 31 Dec 2025 31 Dec 2024
Profitability
ISPC DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 21.55 % 60.93 % 39.46 % 60.93 % 61.8 % 52.43 %
Return on Assets TTM -128.18 % 4.33 % 6.09 % 4.33 % 31.62 % 10.24 %
Return on Equity TTM -531.83 % 6.99 % 13.14 % 6.99 % 69.78 % 20.62 %
Return on Capital Employed TTM -367.68 % 6.7 % 8.41 % 6.7 % 61.76 % 14.25 %
Net Income Per EBT TTM 100 % 85.38 % 92.39 % 85.38 % 80.01 % 90.8 %
EBT Per Ebit TTM 95.08 % 82.4 % 90.83 % 82.4 % 97.36 % 97.03 %
EBIT Per Revenue TTM -361.81 % 20.91 % 17.96 % 20.91 % 31.6 % 21.29 %
Cash Flow To Debt Ratio TTM -2400.67 % 34.84 % 19.85 % 34.84 % 1575.85 % 46.48 %
Receivables Turnover TTM 27.72 6.28 5.01 6.28 7.79 4.67
Payables Turnover TTM 0.55 5.2 - 5.2 14.89 5.8
Inventory Turnover TTM - 3.86 4.97 3.86 4.35 3.22
Fixed Asset Turnover TTM 1025.89 % 444.19 % 421.73 % 444.19 % 575.84 % 343.45 %
Asset Turnover TTM 37.26 % 29.44 % 40.38 % 29.44 % 128.44 % 54.59 %
Operating Cash Flow Per Share TTM -1.16 9.07 20.79 9.07 14.75 5.51
Free Cash Flow Per Share TTM -1.16 7.44 16.74 7.44 13.2 4.07
Cash Per Share TTM 47.65 % 652.48 % 2687.5 % 652.48 % 224.82 % 632.16 %
Operating Cash Flow Sales Ratio TTM -201.52 % 26.12 % 17.55 % 26.12 % 27.46 % 22.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.49 % 81.98 % 80.49 % 81.98 % 89.45 % 73.89 %
Cash Flow Coverage Ratios TTM -2400.67 % 34.84 % 19.85 % 34.84 % 1575.85 % 46.48 %
Price To Free Cash Flows Ratio TTM -0.27 29.11 32.41 29.11 48.69 31.89
Price To Operating Cash Flows Ratio TTM -0.28 23.88 26.11 23.88 43.69 23.52
Price Cash Flow Ratio TTM -0.28 23.88 26.11 23.88 43.69 23.52
Income Statement (TTM)
ISPC DHR-PB TMO DHR IDXX A
Revenue $0.01B $24.57B $44.56B $24.57B $4.3B $6.95B
Gross Profit $0B $14.97B $16.78B $14.97B $2.66B $3.64B
Gross Profit Ratio 42.93% 60.93% 37.66% 60.93% 61.8% 52.43%
EBITDA $-0.01B $6.95B $10.89B $6.95B $1.47B $1.84B
Net Income $-0.01B $3.61B $6.74B $3.61B $1.06B $1.3B
EPS Diluted -17.58 5.04 17.74 5.04 13.08 4.57
Balance Sheet (MRQ)
ISPC DHR-PB TMO DHR IDXX A
Long Term Debt $0B $18.42B $35.85B $18.42B $0.37B $3.05B
Total Liabilities $0.01B $30.93B $56.81B $30.93B $1.75B $5.99B
Total Equity $0B $52.54B $53.54B $52.54B $1.61B $6.74B
Total Investments $0B $0B $0.25B $0B $0B $0.13B
Total Debt $0B $18.42B $39.39B $18.42B $0.85B $3.35B
Total Assets $0.01B $83.46B $110.34B $83.46B $3.35B $12.73B
Cash Flow Statement (TTM)
ISPC DHR-PB TMO DHR IDXX A
Net Income $-0.01B $3.61B $6.72B $3.61B $1.06B $0.43B
Inventory $0B $-0.06B $0B $-0.06B $0B $0.05B
Dividends Paid $0B $-0.88B $-0.64B $-0.88B $0B $-0.28B
Operating Cash Flow $-0.01B $6.42B $7.82B $6.42B $1.18B $1.56B
Capital Expenditure $-0B $-1.16B $-1.53B $-1.16B $-0.12B $-0.41B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 128.9
ACRS Aclaris Therapeutics, Inc. 3.385
ADVB Advanced Biomed Inc. Common Stock 0.255
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 10.369
BIAF bioAffinity Technologies, Inc. 0.993
BIAFW bioAffinity Technologies, Inc. 0.25
BIOC Biocept, Inc. 0.4349
BLLN BillionToOne, Inc. 85.5
BNGO Bionano Genomics, Inc. 1.125
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 28.88
CDNA CareDx, Inc 19.71
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.68
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 165.96
ETFs With Exposure to ISPC
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 341.49
VXF Vanguard Extended Market Index Fund 0 218.255
VTSAX Vanguard Total Stock Market Index Fund 0 166.35
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 166.39
VITSX Vanguard Total Stock Market Index Fund 0 166.38
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 166.41
VEMPX Vanguard Extended Market Index InstlPlus 0 410.63
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 312.11
Unlock